Nerve repair company Orthocell back rattling tin for up to $30 million to turbocharge production
admin 11 hours agoLatest NewsComments Off on Nerve repair company Orthocell back rattling tin for up to $30 million to turbocharge production0 Views
The funds will also support the purchase of a 15 per cent stake in fellow WA biotech, the unlisted Marine Biomedical, and a clinical study into the use of Remplir in prostate cancer surgery.
